67 filings
8-K
BIVI
BioVie Inc - Ordinary Shares
19 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
BIVI
BioVie Inc - Ordinary Shares
11 Mar 24
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
5:00pm
8-K
BIVI
BioVie Inc - Ordinary Shares
6 Mar 24
BioVie Inc. Announces Closing of Public Offering
5:10pm
8-K
BIVI
BioVie Inc - Ordinary Shares
4 Mar 24
BioVie Inc. Announces Proposed Public Offering of Common Stock
7:50am
8-K
BIVI
BioVie Inc - Ordinary Shares
1 Mar 24
Other Events
9:40am
8-K
powlcb4z
25 Jan 24
Other Events
5:00pm
8-K
si7vjn5uf5h
19 Jan 24
Other Events
5:15pm
8-K
0lg4 qveceiq5
29 Nov 23
BioVie Announces EfficacyData from Phase 3 Trial of NE3107 in Patientswith Mild to Moderate Alzheimer’s Disease
8:20am
8-K
3275ro4k
13 Nov 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
jpzx kj0fh
25 Oct 23
Other Events
1:04pm
8-K
z0w 1sr1vun
8 Sep 23
Regulation FD Disclosure
7:13pm
8-K
gbd6usi
6 Apr 23
Other Events
5:44pm
8-K
jrud v4wr
23 Mar 23
Regulation FD Disclosure
5:06pm
8-K
09h hylsehpb23bu4s
13 Mar 23
Amendments to Articles of Incorporation or Bylaws
5:19pm
8-K
if92g db2fu
6 Mar 23
Departure of Directors or Certain Officers
8:00am
8-K
rujfa lom9tm5i
23 Dec 22
Other Events
5:17pm
8-K
k9pm1 g2ws3tk8tv9
14 Dec 22
Other Events
8:29pm
8-K
az19naw
7 Dec 22
Regulation FD Disclosure
4:15pm
8-K
6bdao
6 Dec 22
BioVie Announces Positive Results for NE3107 in Parkinson’s and Alzheimer’s Phase 2 Trials
6:05am
8-K
2365uzqcwz87t
5 Dec 22
Other Events
9:47pm